Patterns of surveillance for late effects of BCR-ABL tyrosine kinase inhibitors in survivors of pediatric Philadelphia chromosome positive leukemias

BACKGROUND: Targeted anticancer therapies such as BCR-ABL tyrosine kinase inhibitors (TKIs) have improved outcomes for chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph + ALL). However, little is known about long-term risks of TKIs in children. Expo...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :BMC Cancer
Главные авторы: Smith, Stephanie M., Sabnis, Himalee S., Lewis, Rebecca Williamson, Effinger, Karen E., Bergsagel, John, Patterson, Briana, Mertens, Ann, Sakamoto, Kathleen M., Schapira, Lidia, Castellino, Sharon M.
Формат: Artigo
Язык:Inglês
Опубликовано: BioMed Central 2021
Предметы:
Research Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC8082962/
https://ncbi.nlm.nih.gov/pubmed/33926411
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-021-08182-z
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы